Consensus Terns Pharmaceuticals, Inc.

Equities

TERN

US8808811074

Market Closed - Nasdaq Other stock markets 21:30:00 06/05/2024 BST			5-day change	1st Jan Change
5.79 ^USD	+6.43%		+13.53%	-10.79%

04-29	Terns Pharmaceuticals, Inc. Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor Tern-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation	CI
04-10	Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer	CI

Evolution of the average Target Price on Terns Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c8e89.xEF8kkx8fvpcKB7ymilqVt0jT-ifju0W0vj31Z_Iwuk.hwku4youJrk3Rn-wzxgmNeVMB9jH7IEn4K-v4dO785CqMiPTeRg7i2pHLg~bb70a1c7c33077e10ba7f6b1315c7464

Analyst Recommendations on Terns Pharmaceuticals, Inc.

UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating	03-27	MT
JMP Securities Cuts Terns Pharmaceuticals Price Target to $15 From $17, Maintains Market Outperform Rating	03-18	MT
BMO Capital Adjusts Price Target on Terns Pharmaceuticals to $19 From $18, Maintains Outperform Rating	03-15	MT
Jefferies Adjusts Terns Pharmaceuticals Price Target to $22 From $18, Maintains Buy Rating	01-18	MT
HC Wainwright Adjusts Price Target on Terns Pharmaceuticals to $5.50 From $8, Maintains Neutral Rating	01-10	MT
Mizuho Adjusts Price Target on Terns Pharmaceuticals to $10 From $17, Maintains Buy Rating	11-27	MT
HC Wainwright Adjusts Price Target on Terns Pharmaceuticals to $8 From $11, Keeps Neutral Rating	10/08/23	MT
Mizuho Ups Price Target on Terns Pharmaceuticals to $17 From $16, Keeps Buy Rating	09/08/23	MT
Mizuho Securities Initiates Terns Pharmaceuticals With Buy Rating, $16 Price Target	22/06/23	MT
Jefferies Initiates Terns Pharmaceuticals at Buy With $18 Price Target	07/06/23	MT
Roth MKM Initiates Terns Pharmaceuticals at Buy With $23 Price Target	31/05/23	MT
JPMorgan Adjusts Price Target on Terns Pharmaceuticals to $10 From $9, Maintains Neutral Rating	16/05/23	MT
BMO Capital Initiates Terns Pharmaceuticals at Outperform With $18 Price Target	08/05/23	MT
JPMorgan Adjusts Price Target on Terns Pharmaceuticals to $9 From $6, Maintains Neutral Rating	29/03/23	MT
HC Wainwright Adjusts Terns Pharmaceuticals' Price Target to $11 From $7, Keeps Neutral Rating	29/03/23	MT
JMP Securities Starts Terns Pharmaceuticals at Market Outperform With $17 Price Target	14/02/23	MT
UBS Initiates Coverage on Terns Pharmaceuticals With Buy Rating, $19 Price Target	07/02/23	MT
HC Wainwright Boosts Price Target on Terns Pharmaceuticals to $7 From $6, Maintains Neutral Rating	29/12/22	MT
Goldman Sachs Adjusts Price Target on Terns Pharmaceuticals to $14 From $9, Maintains Buy Rating	20/12/22	MT
Goldman Sachs Adjusts Price Target on Terns Pharmaceuticals to $9 From $4, Reiterates Buy Rating	28/09/22	MT
HC Wainwright Initiates Terns Pharmaceuticals at Neutral With $6 Price Target	12/09/22	MT
JPMorgan Downgrades Terns Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $6 From $19	23/03/22	MT
TERNS PHARMACEUTICALS : JPMorgan Starts Terns Pharmaceuticals at Overweight With $32 Price Target	02/03/21	MT
TERNS PHARMACEUTICALS : Cowen Initiates Coverage on Terns Pharmaceuticals With Outperform Rating	02/03/21	MT
TERNS PHARMACEUTICALS : Goldman Sachs Starts Terns Pharmaceuticals at Buy With $29 Price Target	02/03/21	MT